Mirae Asset Global Etfs Holdings Ltd. Collegium Pharmaceutical, Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 19,046 shares of COLL stock, worth $561,857. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,046
Previous 18,221
4.53%
Holding current value
$561,857
Previous $522,000
8.81%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding COLL
# of Institutions
254Shares Held
37.2MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$171 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$88.5 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$77.9 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$66.3 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$48.2 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.01B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...